Adverum Biotechnologies Inc. and Farmmi Inc. in race to be NASDAQ top bottom performer of the day
The National Association of Securities Dealers Automated Quotations (NASDAQ) Composite Index opened at 14,204.51 on 29th April 2021. Till 1 PM the highest it touched was 14,211.57 and lowest 13,952.80
Top 5 Bottom Performers Till 1 PM:
Adverum Biotechnologies Inc. (Change -60.19% Priced at $4)
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich’s ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Farmmi Inc. (Change -53.98% Priced at $0.3)
Farmmi, Inc. supplies agricultural products. It focuses on processing and selling edible fungi, mainly Shiitake and Mu Er mushrooms. The company was founded by Ye Fang Zhang and Zheng Yu Wan in 2003 and is headquartered in Lishui, China.
Cara Therapeutics Inc. (Change -45.59% Priced at $14)
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Atomera Inc. (Change -24.08% Priced at $16.8)
Atomera, Inc. engages in the development, commercializing, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears in April 26, 2001 and is headquartered in Los Gatos, CA.
Palisade Bio Inc. (Change -20.49% Priced at $8.1)
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
